SNOA
Sonoma Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.33
+0.38%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $5.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.02
- EPS estimate
- -$0.30
- Revenue actual
- $6.4M
- Revenue estimate
- $5.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +69.0%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026